Farmacología del dolor y de la neurodegeneración
FARMASECR
![Foto de Farmacología del dolor y de la neurodegeneración](/img/grupo.png)
![Foto de Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas](/img/noimage_org.png)
Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (7)
2024
-
Opposing effects of the purinergic P2X7 receptor on seizures in neurons and microglia in male mice
Brain, Behavior, and Immunity, Vol. 120, pp. 121-140
2023
-
Aging, NRF2, and TAU: A Perfect Match for Neurodegeneration?
Antioxidants, Vol. 12, Núm. 8
2022
-
IQM-PC332, a Novel DREAM Ligand with Antinociceptive Effect on Peripheral Nerve Injury-Induced Pain
International Journal of Molecular Sciences, Vol. 23, Núm. 4
-
Multitarget Hybrid Fasudil Derivatives as a New Approach to the Potential Treatment of Amyotrophic Lateral Sclerosis
Journal of Medicinal Chemistry, Vol. 65, Núm. 3, pp. 1867-1882
2021
-
Molecular alterations in sporadic and sod1-als immortalized lymphocytes: Towards a personalized therapy
International Journal of Molecular Sciences, Vol. 22, Núm. 6, pp. 1-17
2019
-
Identification of IQM-266, a novel DREAM ligand that modulates KV4 currents
Frontiers in Molecular Neuroscience, Vol. 12
2009
-
Ca2+/calmodulin-dependent kinase II signalling cascade mediates P2X7 receptor-dependent inhibition of neuritogenesis in neuroblastoma cells
FEBS Journal, Vol. 276, Núm. 18, pp. 5307-5325